Want to see BNGO full AI Analyst Report?
BioNano Genomics (BNGO) Income Statement
BioNano Genomics Income Statement
Last quarter (Q2 2026), BioNano Genomics's total revenue was $8.17M, an increase of 21.36% from the same quarter last year. In Q2, BioNano Genomics's net income was $-7.42M. See BioNano Genomics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 28.51M | $ 30.78M | $ 36.12M | $ 27.80M | $ 17.98M | |
| $ 6.26M | $ 380.00K | $ 9.57M | $ 5.95M | $ 3.87M | |
| $ 39.60M | $ 104.36M | $ 224.81M | $ 137.64M | $ 80.97M | |
| Depreciation and Amortization | $ 9.73M | $ 14.23M | $ 13.71M | $ 9.62M | $ 3.37M |
| $ -16.30M | $ -97.47M | $ -213.60M | $ -120.79M | $ -73.86M | |
| $ -33.34M | $ -103.98M | $ -215.25M | $ -131.70M | $ -77.10M | |
| $ 7.01M | $ -8.00M | $ -17.19M | $ 986.00K | $ -1.05M | |
| $ -26.33M | $ -111.98M | $ -232.43M | $ -130.71M | $ -78.15M | |
| $ -26.39M | $ -112.02M | $ -232.49M | $ -132.60M | $ -72.44M | |
| Per Share Metrics | |||||
| Basic EPS | $ -4.85 | $ -88.13 | $ -408.48 | $ -275.09 | $ -157.02 |
| Diluted EPS | $ -4.85 | $ -88.13 | $ -408.48 | $ -275.09 | $ -157.02 |
| Weighted Average Shares Outstanding | 5.45M | 1.27M | 569.17K | 482.02K | 461.30K |
| Weighted Average Shares Outstanding (Diluted) | 5.45M | 1.27M | 569.17K | 482.02K | 461.30K |
Currency in USD
